Optimal Patient Population in the JAVELIN Bladder 100-trial
In this MEDtalk Jeanny B. Aragon-Ching, Associate Professor, University of Virginia, gives a short overview about the effect for several subgroups of patient in the JAVALIN Blader 100 trial.
